Determination of precipitation inhibitory potential of polymers from amorphous solid dispersions

References

• Butler JM, Dressman JB. The developability classification system: application of biopharmaceutics concepts to formulation development. J Pharm Sci. 2010;99(12):4940–4954.
   PubMed Web of Science ®Google Scholar
• Thiry J, Kok MG, Collard L, et al. Bioavailability enhancement of itraconazole-based solid dispersions produced by hot melt extrusion in the framework of the Three Rs rule. Eur J Pharm Sci. 2017;99:1–8.
   PubMed Web of Science ®Google Scholar
• Raina SA, Eerdenbrugh BV, Alonzo DE, et al. Trends in the precipitation and crystallization behavior of supersaturated aqueous solutions of poorly water‐soluble drugs assessed using synchrotron radiation. J Pharm Sci. 2015;104(6):1981–1992.
   PubMed Web of Science ®Google Scholar
• Raina SA, Zhang GG, Alonzo DE, et al. Enhancements and limits in drug membrane transport using supersaturated solutions of poorly water soluble drugs. J Pharm Sci. 2014;103(9):2736–2748.
   PubMed Web of Science ®Google Scholar
• Alonzo DE, Zhang GG, Zhou D, et al. Understanding the behavior of amorphous pharmaceutical systems during dissolution. Pharm Res. 2010;27(4):608–618.
   PubMed Web of Science ®Google Scholar
• Mistry P, Amponsah-Efah KK, Suryanarayanan R. Rapid assessment of the physical stability of amorphous solid dispersions. Cryst Growth Des. 2017;17(5):2478–2485.
   Web of Science ®Google Scholar
• Alonzo DE, Raina S, Zhou D, et al. Characterizing the impact of hydroxypropylmethyl cellulose on the growth and nucleation kinetics of felodipine from supersaturated solutions. Cryst Growth Des. 2012;12(3):1538–1547.
   Web of Science ®Google Scholar
• Chauhan H, Hui Gu C, Atef E. Correlating the behavior of polymers in solution as precipitation inhibitor to its amorphous stabilization ability in solid dispersions. J Pharm Sci. 2013;102(6):1924–1935.
   PubMed Web of Science ®Google Scholar
• Chauhan H, Kuldipkumar A, Barder T, et al. Correlation of inhibitory effects of polymers on indomethacin precipitation in solution and amorphous solid crystallization based on molecular interaction. Pharm Res. 2014;31(2):500–515.
   PubMed Web of Science ®Google Scholar
• Ilevbare GA, Liu H, Edgar KJ, et al. Inhibition of solution crystal growth of ritonavir by cellulose polymers–factors influencing polymer effectiveness. CrystEngComm. 2012;14(20):6503–6514.
   Web of Science ®Google Scholar
• Ilevbare GA, Liu H, Edgar KJ, et al. Maintaining supersaturation in aqueous drug solutions: impact of different polymers on induction times. Cryst Growth Des. 2012;13(2):740–751.
   Web of Science ®Google Scholar
• Ilevbare GA, Liu H, Edgar KJ, et al. Understanding polymer properties important for crystal growth inhibition- impact of chemically diverse polymers on solution crystal growth of ritonavir. Cryst Growth Des. 2012;12(6):3133–3143.
   Web of Science ®Google Scholar
• Prasad D, Chauhan H, Atef E. Role of molecular interactions for synergistic precipitation inhibition of poorly soluble drug in supersaturated drug–polymer–polymer ternary solution. Mol Pharm. 2016;13(3):756–765.
   PubMedGoogle Scholar
• Chavan RB, Thipparaboina R, Kumar D, et al. Evaluation of the inhibitory potential of HPMC, PVP and HPC polymers on nucleation and crystal growth. RSC Adv. 2016;6(81):77569–77576.
   Web of Science ®Google Scholar
• Gupta P, Chawla G, Bansal AK. Physical stability and solubility advantage from amorphous celecoxib: the role of thermodynamic quantities and molecular mobility. Mol Pharm. 2004;1(6):406–413.
   PubMedGoogle Scholar
• Choi J-S, Park J-S. Design of PVP/VA S-630 based tadalafil solid dispersion to enhance the dissolution rate. Eur J Pharm Sci. 2017;97:269–276.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Huo M, Zhou J, et al. DDSolver: an add-in program for modeling and comparison of drug dissolution profiles. AAPS J. 2010;12(3):263–271.
   PubMed Web of Science ®Google Scholar
• Kumar D, Thipparaboina R, Modi SR, et al. Effect of HPMC concentration on crystal habit of nifedipine. Cryst Eng Comm. 2015;17(7):1615–1624.
   Google Scholar
• Grooff D, De Villiers M, Liebenberg W. Thermal methods for evaluating polymorphic transitions in nifedipine. Thermochim Acta. 2007;454(1):33–42.
   Web of Science ®Google Scholar
• Kini A, Patel SB. Phase behavior, intermolecular interaction, and solid state characterization of amorphous solid dispersion of Febuxostat. Pharm Dev Technol. 2017;22(1):45–57.
   PubMed Web of Science ®Google Scholar
• Ziaee A, Albadarin AB, Padrela L, et al. Spray drying ternary amorphous solid dispersions of ibuprofen–an investigation into critical formulation and processing parameters. Euro J Pharm Biopharm. 2017;120:43–51.
   PubMed Web of Science ®Google Scholar
• Baird JA, Taylor LS. Evaluation of amorphous solid dispersion properties using thermal analysis techniques. Adv Drug Del Rev. 2012;64(5):396–421.
   PubMed Web of Science ®Google Scholar
• Cilurzo F, Minghetti P, Casiraghi A, et al. Characterization of nifedipine solid dispersions. Int J Pharm. 2002;242(1-2):313–317.
   PubMedGoogle Scholar
• Triggle A, Shefter E, Triggle D. Crystal structures of calcium channel antagonists: 2, 6-dimethyl-3, 5-dicarbomethoxy-4-[2-nitro-, 3-cyano-, 4-(dimethylamino)-, and 2, 3, 4, 5, 6-pentafluorophenyl]-1, 4-dihydropyridine. J Med Chem. 1980;23(12):1442–1445.
   PubMed Web of Science ®Google Scholar
• Meng F, Trivino A, Prasad D, et al. Investigation and correlation of drug polymer miscibility and molecular interactions by various approaches for the preparation of amorphous solid dispersions. Eur J Pharm Sci. 2015;71, 12–24.
   PubMed Web of Science ®Google Scholar
• Higashi K, Hayashi H, Yamamoto K, et al. The effect of drug and EUDRAGIT® S 100 miscibility in solid dispersions on the drug and polymer dissolution rate. Int J Pharm. 2015;494(1):9–16.
   PubMedGoogle Scholar
• Semjonov K, Kogermann K, Laidmäe I, et al. The formation and physical stability of two-phase solid dispersion systems of indomethacin in supercooled molten mixtures with different matrix formers. Eur J Pharm Sci. 2017;97:237–246.
   PubMed Web of Science ®Google Scholar